Thierry Guillaudeux is Chief Scientific Officer at KINETA, INC./DE (KANT). They have made 1 open-market trade across 1 company since 2023, most recently 2025-06-30.
CIK 0001958094
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KA | BUY | 2023-09-14 | 2023-09-15 | $2.00 | $20K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.